Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease
Clinical trial NCT02046733 · COMPLETED
Trial details
- NCT number
- NCT02046733
- Sponsor
- ETOP IBCSG Partners Foundation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-18
- Primary completion
- 2020-05-25
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.